Archives
-
Nanoplastic–Cadmium Apoptosis via IP3R/Ca2+/STAT3
2026-09-05
A 2026 Toxicology study shows that polystyrene nanoplastics and cadmium jointly promote intestinal apoptosis in Caenorhabditis elegans and Caco-2 cells. Its key contribution is mechanistic evidence linking co-exposure to IP3R activation, cytosolic Ca2+ elevation, STAT3 phosphorylation, and apoptosis, with pathway-directed inhibition supporting a causal role for calcium signaling.
-
BGJ398 Workflow for FGFR Mechanism Studies
2026-09-04
BGJ398 (NVP-BGJ398) combines nanomolar FGFR1/2/3 activity with strong kinase selectivity, making it useful for separating receptor-dependent signaling from nonspecific toxicity. This guide translates that profile into practical oncology and developmental-biology workflows, with assay design, protocol starting points, and troubleshooting strategies.
-
Degarelix acetate: Assays and Workflow Guide
2026-09-04
Build reproducible GnRH receptor, reporter, and hormone-secretion assays with Degarelix acetate while separating receptor potency from duration of endocrine action. This workflow combines formulation control, dose–response design, and reference-backed troubleshooting for prostate cancer research and pituitary hormone regulation.
-
IWP-L6 Workflow for Wnt Signaling Studies
2026-09-03
IWP-L6 provides a precise way to suppress ligand-dependent Wnt output at the Porcn enzyme step, enabling cleaner pathway-causality experiments than endpoint-only assays. This guide translates its sub-nanomolar potency into practical workflows for HEK293 signaling, osteoblast metabolism, kidney branching, and zebrafish regeneration studies.
-
L-Alanyl-L-Glutamine: From Nutrient to Assay Variable
2026-09-03
L-Alanyl-L-glutamine can be more than a nutritional supplement dipeptide: it can function as a carefully controlled experimental variable in barrier, stress, and inflammation studies. This article connects molecular handling, assay design, and evidence boundaries to improve interpretation of gastrointestinal research.
-
IWR-1-endo: From Wnt Control to Translation
2026-09-02
A translational framework for using IWR-1-endo to interrogate Wnt/β-catenin biology, validate pathway dependence, and connect mechanistic experiments with cell-state-resolved disease models.
-
Praeruptorin A Workflow for Ferroptosis Research
2026-09-02
Build mechanism-led workflows with Praeruptorin A, from Fe²⁺ screening and DMT1 validation to doxorubicin cardiomyopathy research. The same angular pyranocoumarin compound also supports comparative studies of intestinal barrier inflammation and tumor-cell invasion when concentration, vehicle, and timing are controlled.
-
Silybin A for Silymarin Liver Research
2026-09-01
Build reproducible liver and cancer biology assays with chemically defined Silybin A rather than relying on extract-level attribution. This workflow combines DMSO handling, dose–response design, oxidative-stress and fibrosis endpoints, and a metastasis-focused assay strategy adapted cautiously from ERK/MMP1 research.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-09-01
The reference study identifies CD44-mediated metabolic rewiring as a dependency of IDH-mutant leukemia, linking pentose phosphate pathway activity and NADPH production to sustained R-2HG synthesis. Its isogenic genetic models and combination experiments suggest that disrupting both mutant IDH activity and CD44-dependent metabolism may address vulnerabilities not fully controlled by IDH inhibition alone.
-
Nanocarrier-Mediated dsRNA Transdermal Delivery
2026-08-31
Guan and colleagues investigate how star cationic polymer nanocarriers help double-stranded RNA cross the insect cuticle, focusing on wax-layer disruption, improved wetting, and reduced resistance at the chitin layer. The study provides a mechanistic framework for noninvasive transdermal RNA interference delivery while also clarifying which barriers must be addressed in future formulations.
-
Angiotensin II: From Pressor Signal to Fibrosis
2026-08-31
Angiotensin II is more than a hypertension stimulus: it can connect receptor signaling with inflammatory and fibrotic assay design. This guide uses renal fibrosis evidence to build a practical framework for vascular, renal, and remodeling studies.
-
PX-478 2HCl: A Translational Hypoxia Strategy
2026-08-30
PX-478 2HCl provides a pharmacological route to interrogate HIF-1α across tumor hypoxia, radiation response, and ischemic microenvironments. This thought-leadership perspective connects product evidence with emerging metabolic and inflammatory biology while defining practical validation strategies and translational limits.
-
Ouabain Workflows for Na+/K+-ATPase Assays
2026-08-29
Ouabain enables controlled interrogation of Na+/K+-ATPase activity, sodium–calcium coupling, and cardiotonic steroid physiology across cell and animal studies. This practical guide separates pump inhibition from secondary growth or death effects so researchers can build more informative ion-transport, cardiovascular, and myocardial infarction experiments.
-
Ceruletide: Reproducible Pancreatic Models
2026-08-28
A scenario-driven guide to using Ceruletide (SKU B8465) in pancreatic function research, gastrointestinal physiology studies, and injury-related cell assays. It covers solvent compatibility, controls, assay interpretation, storage, and practical criteria for selecting a reliable Ceruletide supplier.
-
Pcbp1, Mitochondria, and B-Cell Antibody Responses
2026-08-28
The reference study identifies the RNA-binding protein Pcbp1 as a posttranscriptional regulator of mitochondrial integrity, protein translation, and humoral immunity in B cells. Its mechanistic link to Fdxr, mitochondrial complex I, and germinal center function provides a framework for interpreting how metabolic defects can limit antibody production.